These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19208095)

  • 41. Pulmonary fibrosis in dyskeratosis congenita: a case report with a PRISMA-compliant systematic review.
    Wang P; Xu Z
    BMC Pulm Med; 2021 Sep; 21(1):279. PubMed ID: 34479523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.
    Vulliamy TJ; Knight SW; Mason PJ; Dokal I
    Blood Cells Mol Dis; 2001; 27(2):353-7. PubMed ID: 11259155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.
    Ballew BJ; Savage SA
    Expert Rev Hematol; 2013 Jun; 6(3):327-37. PubMed ID: 23782086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations.
    Marrone A; Sokhal P; Walne A; Beswick R; Kirwan M; Killick S; Williams M; Marsh J; Vulliamy T; Dokal I
    Haematologica; 2007 Aug; 92(8):1013-20. PubMed ID: 17640862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance.
    Mason PJ; Wilson DB; Bessler M
    Curr Mol Med; 2005 Mar; 5(2):159-70. PubMed ID: 15974869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita.
    Vieri M; Kirschner M; Tometten M; Abels A; Rolles B; Isfort S; Panse J; Brümmendorf TH; Beier F
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
    Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
    PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dyskeratosis congenita.
    Gupta V; Kumar A
    Adv Exp Med Biol; 2010; 685():215-9. PubMed ID: 20687509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation.
    Vulliamy TJ; Marrone A; Knight SW; Walne A; Mason PJ; Dokal I
    Blood; 2006 Apr; 107(7):2680-5. PubMed ID: 16332973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dyskeratosis congenita mutations in the H/ACA domain of human telomerase RNA affect its assembly into a pre-RNP.
    Trahan C; Dragon F
    RNA; 2009 Feb; 15(2):235-43. PubMed ID: 19095616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutations of telomerase complex genes linked to bone marrow failures.
    Yamaguchi H
    J Nippon Med Sch; 2007 Jun; 74(3):202-9. PubMed ID: 17625368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Dyskeratosis congenita, a disease caused by defective telomere maintenance].
    Hoareau-Aveilla C; Henry Y; Leblanc T
    Med Sci (Paris); 2008 Apr; 24(4):390-8. PubMed ID: 18405638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stem cells, telomerase and dyskeratosis congenita.
    Mason PJ
    Bioessays; 2003 Feb; 25(2):126-33. PubMed ID: 12539238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of mutations in TERT, the genes for telomerase reverse transcriptase, in Indian patients of aplastic anaemia: a pilot study.
    Mehta S; Krishnamohan M; Gulati S; Sharmat N; Vashishtha P; Singh I
    J Assoc Physicians India; 2014 Oct; 62(10):13-7. PubMed ID: 25906515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A TIN2 dyskeratosis congenita mutation causes telomerase-independent telomere shortening in mice.
    Frescas D; de Lange T
    Genes Dev; 2014 Jan; 28(2):153-66. PubMed ID: 24449270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Follow-Up of a Case with Dyskeratosis Congenita Caused by NHP2-V126M/X154R Mutation: Genotype-Phenotype Association.
    Erdem M; Tüfekçi Ö; Yılmaz Ş; Alacacıoğlu İ; Ören H
    Acta Haematol; 2019; 141(1):28-31. PubMed ID: 30472699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Telomeres and marrow failure.
    Calado RT
    Hematology Am Soc Hematol Educ Program; 2009; ():338-43. PubMed ID: 20008219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1.
    Carrascoso-Rubio C; Zittersteijn HA; Pintado-Berninches L; Fernández-Varas B; Lozano ML; Manguan-Garcia C; Sastre L; Bueren JA; Perona R; Guenechea G
    Stem Cell Res Ther; 2021 Jan; 12(1):92. PubMed ID: 33514435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.
    Brault ME; Lauzon C; Autexier C
    Hum Mol Genet; 2013 Sep; 22(17):3498-507. PubMed ID: 23660516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical features of dyskeratosis congenita in mainland China: case reports and literature review.
    Li F; Li W; Qiao X; Xie X
    Int J Hematol; 2019 Mar; 109(3):328-335. PubMed ID: 30604317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.